WHO-GMP sourced EU-GMP partners ISO 9001:2015 49+ export markets Since 2003

Prezista (darunavir) is an HIV-1 protease inhibitor taken with a booster and food, supplied as film-coated tablets from 75 mg to 800 mg that need no cold chain.

M Care Exports supplies darunavir, as the originator Prezista and as Indian-made lines, to hospitals, HIV programmes, licensed importers and tender authorities internationally, with established supply lanes into the GCC, Africa and Europe. If you are looking for darunavir 600 mg or 800 mg tablets, send the destination, strength and quantity, and we quote per destination.

WhatsApp a darunavir enquiry → Send enquiry by form
WHO-GMP sourcing CDSCO licensed exporter EU-GMP capable partners Cold-chain validated (2–8°C & −25°C) CTD / eCTD dossier-ready ISO 9001:2015
Bulk supply and export terms

Darunavir exporter and bulk supplier from India.

"We need a partner for darunavir" is a typical enquiry from an HIV clinic pharmacy, a ministry of health tender desk or a licensed importer. M Care Exports is a merchant-exporter, so we quote against your specification and confirm which line your destination accepts. We supply originator or regulator-registered brands such as Prezista and Indian-made lines from our catalogue, for example Daruvir, Virem and Danavir tablets, where the destination's registration route accepts them. We do not claim that any Indian-made line is registered in a given country. Darunavir is an oral tablet with no cold chain, so the quote turns on strength (the US label's adult doses use one 800 mg tablet once daily or one 600 mg tablet twice daily), plain darunavir or a fixed combination with ritonavir, pack size, quantity, the registration route in the destination and Incoterms.

Source

WHO-GMP-certified Indian manufacturing line, named on every quote.

Minimum order

No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.

Pricing

On request. Indicative FOB or CIF quote, formal proforma on confirmation.

Incoterms

EXW, FOB, CIF, CIP or DAP.

Payment

Letter of credit (sight or usance) and telegraphic transfer.

Documentation

WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.

Shelf-life

Minimum remaining shelf-life agreed per order and confirmed on the proforma.

Response

Availability and CoPP status within two working days; pre-alert documents before dispatch.

Request a bulk quote → Send a bulk enquiry by form How bulk supply works
At a glance

HIV-1 protease inhibitor, used with ritonavir or cobicistat, sourced and documented for export.

Darunavir is an HIV-1 protease inhibitor (the UK SmPC gives the pharmacotherapeutic group as antivirals for systemic use, protease inhibitors, ATC J05AE10). The US label (Janssen Products LP, DailyMed page updated August 2025) says Prezista is co-administered with ritonavir and other antiretroviral agents for HIV-1 infection in adult and paediatric patients 3 years of age and older. It lists tablets of 75 mg, 150 mg, 600 mg and 800 mg and an oral suspension of 100 mg/mL. The EMA page for Prezista names Janssen-Cilag International NV as the marketing authorisation holder and says it is taken with low-dose ritonavir, or with cobicistat in adults and adolescents aged 12 years and older weighing at least 40 kg. The UK emc SmPC for the 800 mg tablet shows Janssen-Cilag Limited as holder and names 400 mg and 800 mg tablets alongside the 75 mg, 150 mg and 600 mg tablets. The US label dosing for treatment-naive adults is 800 mg once daily with ritonavir 100 mg once daily, with food. For treatment-experienced adults with at least one darunavir resistance-associated substitution, or where genotypic testing is not feasible, it is 600 mg twice daily with ritonavir 100 mg.

Active ingredient

Darunavir (as darunavir ethanolate in Prezista, per the UK SmPC). HIV-1 protease inhibitor, used with ritonavir or cobicistat.

Forms and strengths

75 mg film-coated tablet; 150 mg film-coated tablet; 400 mg film-coated tablet (EU and UK labels); 600 mg film-coated tablet; 800 mg film-coated tablet; 100 mg/mL oral suspension (US label).

Indications

Darunavir (Prezista) is an HIV-1 protease inhibitor from Janssen, taken with ritonavir or cobicistat and other antiretrovirals, as set out in the US, EU and UK labelling.

Administration

Oral. Film-coated tablet; oral suspension (Prezista).

Documentation

Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.

Who we supply

Hospital pharmacies, licensed importers and tender desks across our export markets.

India is our origin. We do not sell into the Indian market.

Buyers are HIV clinic and hospital pharmacists, ministry of health and hospital tender desks, and licensed importers and distributors. Typical enquiries read "I'm looking for darunavir 800 mg tablets for an HIV programme" or "We need a partner for darunavir 600 mg and ritonavir for a tender". M Care Exports supplies hospitals, licensed importers, distributors and government tender authorities internationally, with established supply lanes into the GCC, Africa and Europe. Each destination has its own route to registration or import, for example the Emirates Drug Establishment (EDE) in the UAE, NAFDAC in Nigeria and the MHRA in the UK, and we align the offer with it before quoting. Whether the destination accepts the originator, a regulator-registered generic or an Indian-made line depends on the regulator, and M Care Exports confirms the route per enquiry.

GCC registration routes

Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.

MoH registration, GCC →

UK unlicensed routes

Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.

MHRA Specials →

Tender desks

Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.

Tender response →

Dossier support

CTD documentation from the sourcing manufacturer, compiled for your regulator's format.

Dossier preparation →

Pharmacist's note

What the dispensing pharmacist checks on darunavir.

The labels pair darunavir with a booster and other antiretrovirals, so check the booster before you check the strength. The US label says Prezista must be co-administered with ritonavir and food, and names ritonavir only. The UK SmPC allows either cobicistat 150 mg or ritonavir 100 mg, and tells patients to take the tablet with the booster within 30 minutes after a meal. Dose differs by treatment history. In the US label, 800 mg once daily with ritonavir suits treatment-naive adults and treatment-experienced adults without darunavir resistance-associated substitutions, while 600 mg twice daily with ritonavir applies where there is at least one substitution or genotypic testing is not feasible, and for pregnant patients. The UK SmPC sets its once-daily criteria for experienced patients at HIV-1 RNA below 100,000 copies/mL and CD4+ count of at least 100 cells x 10^6/L. Darunavir contains a sulphonamide moiety, so both labels advise caution in known sulphonamide allergy. Both labels also carry hepatotoxicity warnings, and the UK SmPC contraindicates severe (Child-Pugh Class C) hepatic impairment. Tablets are not cold chain: the UK SmPC states no special storage conditions and a 3-year shelf life for the 800 mg tablet, and the US label says to store tablets at 25 °C (77 °F).

Regulatory & quality

The documentation pack a regulator actually asks for.

Darunavir is a room-temperature oral solid, so the documentation question is registration rather than temperature control. The US label gives storage at 25 °C (77 °F) for tablets, and the UK SmPC for the 800 mg tablet states no special storage conditions and a 3-year shelf life, in an HDPE bottle of 30 tablets with a child-resistant closure. The UK emc search for darunavir lists the originator Prezista from Janssen-Cilag Ltd, the Rezolsta combination, and several darunavir tablets from other companies. The US DailyMed listing for darunavir shows Prezista from Janssen Products LP, the Prezcobix and Symtuza combinations, and darunavir tablet labels from a number of other companies. In the EU, the EMA lists Darunavir Krka and Darunavir Viatris as generic medicines whose reference medicine is Prezista. The WHO Model List of Essential Medicines 2023 lists darunavir as a 75 mg, 400 mg, 600 mg and 800 mg tablet in its protease inhibitor section, with the note "> 3 years". M Care Exports is a merchant-exporter. We state the source and status of each line before quoting, and we confirm the documents the destination regulator asks for per enquiry.

CoA and MoA, per batch

Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.

CoPP, WHO-GMP, MFG licence

Certificate of pharmaceutical product, site GMP certificate and manufacturing licence, issued by the state drug regulator and naming the actual manufacturing site.

CTD Module 3

Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.

Pack insert, labels, artwork

Destination-language patient information and labelling to the local regulator's standard, locked before shipment.

Pharmacovigilance

A named PV contact arranged in the destination market where the registration requires one.

How the enquiry works

Molecule · strength · volume · destination. One working day to a quote.

  1. Send us the specifics. Form and strength, pack preference, destination market and indicative volume for darunavir.
  2. We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
  3. Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
  4. Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
  5. After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Frequently asked

Darunavir supply, the specific questions.

Is there a generic of Prezista, and what is Prezista's generic name?

The generic (non-proprietary) name of Prezista is darunavir. In the US, DailyMed lists darunavir tablets from other companies, including Cipla, Aurobindo, Lupin and Zydus, under the ANDA (generic) marketing category, alongside Prezista from Janssen Products LP. In the EU, the EMA lists Darunavir Krka and Darunavir Viatris (previously Darunavir Mylan) as generic medicines with Prezista as the reference medicine. In the UK, the emc lists darunavir 400 mg, 600 mg and 800 mg film-coated tablets from companies such as Amarox, MSN Laboratories Europe, Viatris and Dr. Reddy's, next to Prezista from Janssen-Cilag. M Care Exports supplies both originator Prezista and Indian-made lines.

What sets the landed price of Prezista or darunavir for an importer?

We do not publish prices. The landed cost depends on whether you want the originator Prezista or an Indian-made line, the strength, the pack size, the quantity, the registration route in your destination and Incoterms. Darunavir tablets need no cold chain, so freight is usually simpler than for biologics. M Care Exports quotes per destination once you send the strength, volume and country, and says in the quote which line is offered.

Which Indian-made darunavir brands does M Care Exports supply?

Our catalogue includes Indian-made darunavir lines such as Daruvir (600 mg and 800 mg), Virem 600 mg and Danavir 600 mg tablets, as well as darunavir and ritonavir combination lines. We supply them for destinations whose registration accepts them. We do not claim that these brands are registered in any destination, and we do not describe them as generics unless a regulator source does. Tell us the country and strength and we confirm whether the line suits your route.

Does darunavir need ritonavir or cobicistat?

Yes, darunavir is dosed with a booster. The US Prezista label says it must be co-administered with ritonavir and food. The UK SmPC and the EMA page also describe cobicistat as an alternative booster, in adults and adolescents aged 12 and older weighing at least 40 kg. The WHO Model List note says protease inhibitors other than ritonavir should be used in boosted forms, for example with ritonavir. Tell us whether you need plain darunavir tablets or a fixed combination such as darunavir with ritonavir, and we quote that line.

Which strengths of darunavir are authorised, and which does WHO list?

The US label lists tablets of 75, 150, 600 and 800 mg and a 100 mg/mL oral suspension. The EU product information on the EMA Prezista page names 75, 150, 400, 600 and 800 mg tablets, and the UK SmPC says the 400 mg and 800 mg tablets can be used to construct the once-daily 800 mg regimen. The WHO Model List 2023 lists darunavir tablets of 75 mg, 400 mg, 600 mg and 800 mg, with the note "> 3 years". Strength availability differs by destination and by line, so M Care Exports confirms it per enquiry.

Does Prezista need cold-chain shipping or special storage?

No. The UK SmPC for the 800 mg tablet states that the product does not require any special storage conditions, with a shelf life of 3 years. The US label says to store Prezista tablets and oral suspension at 25 °C (77 °F), and not to refrigerate or freeze the oral suspension. For export, the practical checks are remaining shelf life at dispatch, the pack format your destination accepts and the labelling its regulator requires, which M Care Exports confirms per enquiry.

Sources and review

Who stands behind this page, and where its statements come from.

Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-11-15.

This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.

Darunavir enquiry

Send the specifics. You'll have a price inside one working day.

Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.

WhatsApp the Mumbai desk → Enquiry form Back to antivirals & hiv